Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Acta Biomaterialia|April 20, 2013
Caveolin: a possible biomarker of degradable metallic materials toxicity in vascular cellsAgung Purnama, Diego Mantovani, Jacques CouetAnti-Cancer Drugs|October 30, 2004
G2/M blockade by paclitaxel induces caveolin-1 expression in A549 lung cancer cells: caveolin-1 as a marker of cytotoxicityElise Roussel, Martin M Bélanger, Jacques CouetJournal of the American College of Cardiology|April 8, 2003
Experimental aortic valve stenosis in rabbitsMarie-Claude Drolet, Marie Arsenault, Jacques CouetPeerj|March 25, 2021
Segmental analysis by speckle-tracking echocardiography of the left ventricle response to isoproterenol in male and female miceElisabeth Walsh-Wilkinson, Marie Arsenault, Jacques CouetAnti-Cancer Drugs|April 8, 2003
Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cellsMartin M Bélanger, Elise Roussel, Jacques CouetActa Biomaterialia|February 24, 2010
Assessing the biocompatibility of degradable metallic materials: state-of-the-art and focus on the potential of genetic regulationAgung Purnama, Hendra Hermawan, Jacques Couet, et al.Cancer Biology & Therapy|August 25, 2004
Role of caveolin-1 in etoposide resistance development in A549 lung cancer cellsMartin M Bélanger, Martin Gaudreau, Elise Roussel, et al.The Journal of Heart Valve Disease|February 15, 2002
Experimental aortic regurgitation in rats under echocardiographic guidanceMarie Arsenault, Eric Plante, Marie-Claude Drolet, et al.Acta Biomaterialia|March 19, 2013
Gene expression profile of mouse fibroblasts exposed to a biodegradable iron alloy for stentsAgung Purnama, Hendra Hermawan, Serge Champetier, et al.The Journal of Heart Valve Disease|September 8, 2012
Effects of spironolactone treatment on an experimental model of chronic aortic valve regurgitationAdnane Zendaoui, Dominic Lachance, Elise Roussel, et al.Pageof 6